Lixte Biotechnology Holdings (LIXT) Financials

$3.66

$-0.65 (-15.08%)

As on 03-Sep-2026 09:30EDT

Market cap

$125 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	7.96	5.11	3.57	5.09	6.31	6.72
Operating Profit (EBIT)	-7.96	-5.11	-3.57	-5.09	-6.31	-6.72
Other Income	--	--	--	--	--	--
Profit before Tax	-8.75	-6.01	-3.59	-5.09	-6.31	-6.73
Provision for Tax	--	--	--	-0.01	-0.01	0.01
Profit after Tax (Net Income)	-8.69	-6.01	-3.59	-5.09	-6.31	-6.73
Minority Interest	0.06	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-6.73

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	23.91	9.66	0.83	3.99	5.17	4.79
Minority Interest	0.06	--	--	--	--	--
Non-Current Liabilities	0.16	0.44	--	--	0.39	0.30
Current Liabilities	1.50	1.33	0.32	0.31	0.39	0.30
Total Liabilities	28.15	12.73	1.15	4.31	5.56	5.09

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	7.35	7.56	0.11	0.08	0.15	0.15
Current Assets	19.30	5.18	1.04	4.23	5.56	5.09
Total Assets	45.95	12.73	1.15	4.31	5.56	5.09
Total Debt*	1.10	0.66	--	--	--	--
Net Current Assets	--	3.85	0.83	3.99	5.17	4.79

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-3.07	-3.16	-4.29	-4.61	-4.14
Cash Flow from Investing Activities	--	-3.17	--	--	5.14	--
Cash from Financing Activities	--	10.31	--	3.14	5.14	3.90
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.72	-0.12	-1.59	-2.26	-3.79	-4.89
Cash EPS ($)	--	-0.12	-1.59	-2.26	-3.79	-4.89
Adjusted Book Value ($)	--	0.20	0.37	1.78	3.10	3.48
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.06	-1.41	-1.91	-2.77	-3.01
Free Cash Flow per Share ($)	--	-0.06	-1.41	-1.91	-2.77	-3.01

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-107.74	-148.73	-111.07	-126.81	-137.28
ROE (%)	-51.36	-114.56	-148.73	-111.07	-126.81	-137.28
ROA (%)	-36.44	-86.60	-131.50	-103.09	-118.51	-130.37
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-221,534.63	--	29.17	19.42	6.18	-106.08
Net Profit Growth (%)	-179.11	-67.58	29.51	19.41	6.18	-106.08
EPS Growth (%)	43.93	0.92	0.29	0.40	0.23	-0.74
Book Value Growth (%)	641.02	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-31.66	-1.27	-1.04	-0.13	-0.24
Price / Book Value	3.15	19.69	5.52	1.32	0.16	0.34
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.50	-30.96	-0.99	-0.21	0.71	0.47
Close Price ($)	7.42	3.93	2.03	2.35	5.09	11.90
High Price ($)	8.25	6.26	4.40	27.00	49.50	71.90
Low Price ($)	0.90	0.64	1.31	1.58	4.32	11.08
Market Cap ($ Cr)	125.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.07	--	--	--	--
Short term debt to equity ratio	0.04	0.07	--	0.08	0.08	0.06
Current Ratio	12.87	3.88	3.26	13.48	14.08	16.81
Quick Ratio	12.87	--	--	--	--	--
Interest Coverage	-1,071.25	--	-214.20	-313.36	-711.27	-907.53

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.